Series B - X4 Pharmaceuticals - Nov 16, 2017 Funding Round Profile - Cointime

Bitcoin $86,532.09 -2.53%
Ethereum $3,165.75 -5.49%
BNB $601.49 -7.57%
Optimism $1.53 -14.17%
Arbitrum $0.58 -12.35%
Solana $201.75 -8.24%
Polygon $0.37 -11.84%
Cosmos $4.93 -11.61%
Avalanche $31.69 -10.37%

Bitcoin $86,532.09 -2.53%
Ethereum $3,165.75 -5.49%
BNB $601.49 -7.57%
Optimism $1.53 -14.17%
Arbitrum $0.58 -12.35%
Solana $201.75 -8.24%
Polygon $0.37 -11.84%
Cosmos $4.93 -11.61%
Avalanche $31.69 -10.37%

X4 Pharmaceuticals

company

Funding Round

Series B

Money Raised

$ 27M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Cormorant Asset Management	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Dec 15, 2015	Series A	$ 37.49M	Cormorant Asset Management	Detail
Jan 1, 2014	Seed	0	SV Health Investors	Detail